These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 9192923)
1. Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Dutch CNSLD Study Group. Brand PL; Duiverman EJ; Postma DS; Waalkens HJ; Kerrebijn KF; van Essen-Zandvliet EE Eur Respir J; 1997 Jun; 10(6):1242-7. PubMed ID: 9192923 [TBL] [Abstract][Full Text] [Related]
2. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group. Brand PL; Duiverman EJ; Waalkens HJ; van Essen-Zandvliet EE; Kerrebijn KF Thorax; 1999 Feb; 54(2):103-7. PubMed ID: 10325912 [TBL] [Abstract][Full Text] [Related]
3. Airway responsiveness to acetaldehyde in patients with asthma: relationship to methacholine responsiveness and peak expiratory flow variation. Prieto L; Sánchez-Toril F; Brotons B; Soriano S; Casañ R; Belenguer JL Clin Exp Allergy; 2000 Jan; 30(1):71-8. PubMed ID: 10606933 [TBL] [Abstract][Full Text] [Related]
4. Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness. Dutch Chronic Non-Specific Lung Disease study group. Douma WR; Kerstjens HA; Roos CM; Koëter GH; Postma DS Eur Respir J; 2000 Aug; 16(2):220-5. PubMed ID: 10968495 [TBL] [Abstract][Full Text] [Related]
5. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group. Kerstjens HA; Brand PL; de Jong PM; Koëter GH; Postma DS Thorax; 1994 Nov; 49(11):1109-15. PubMed ID: 7831626 [TBL] [Abstract][Full Text] [Related]
6. Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability? den Otter JJ; Reijnen GM; van den Bosch WJ; van Schayck CP; Molema J; van Weel C Br J Gen Pract; 1997 Aug; 47(421):487-92. PubMed ID: 9302787 [TBL] [Abstract][Full Text] [Related]
7. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The Dutch CNSLD Study Group. Brand PL; Postma DS; Kerstjens HA; Koëter GH Am Rev Respir Dis; 1991 May; 143(5 Pt 1):916-21. PubMed ID: 2024843 [TBL] [Abstract][Full Text] [Related]
8. Which index of peak expiratory flow is most useful in the management of stable asthma? Reddel HK; Salome CM; Peat JK; Woolcock AJ Am J Respir Crit Care Med; 1995 May; 151(5):1320-5. PubMed ID: 7735580 [TBL] [Abstract][Full Text] [Related]
9. Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing. Prieto L; Gutiérrez V; Morales C; Perpiñan J; Inchaurraga I Ann Allergy Asthma Immunol; 1998 Feb; 80(2):151-8. PubMed ID: 9494447 [TBL] [Abstract][Full Text] [Related]
10. Airway responsiveness and peak flow variability in the diagnosis of asthma for epidemiological studies. Lewis SA; Weiss ST; Britton JR Eur Respir J; 2001 Dec; 18(6):921-7. PubMed ID: 11829097 [TBL] [Abstract][Full Text] [Related]
11. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma. Leroyer C; Perfetti L; Trudeau C; L'Archevĕque J; Chan-Yeung M; Malo JL Am J Respir Crit Care Med; 1998 Sep; 158(3):827-32. PubMed ID: 9731012 [TBL] [Abstract][Full Text] [Related]
12. Bronchial responsiveness, oscillations of peak flow rate and symptoms in patients with mitral stenosis. Rolla G; Bucca C; Brussino L; Bugiani M; Bergerone S; Malara D; Morea M Eur Respir J; 1992 Feb; 5(2):213-8. PubMed ID: 1559586 [TBL] [Abstract][Full Text] [Related]
13. Peak expiratory flow variability adjusted by forced expiratory volume in one second is a good index for airway responsiveness in asthmatics. Matsunaga K; Kanda M; Hayata A; Yanagisawa S; Ichikawa T; Akamatsu K; Koarai A; Hirano T; Sugiura H; Minakata Y; Ichinose M Intern Med; 2008; 47(12):1107-12. PubMed ID: 18552467 [TBL] [Abstract][Full Text] [Related]
14. Maximal airway response to methacholine in cough-variant asthma: comparison with classic asthma and its relationship to peak expiratory flow variability. Kang H; Koh YY; Yoo Y; Yu J; Kim DK; Kim CK Chest; 2005 Dec; 128(6):3881-7. PubMed ID: 16354858 [TBL] [Abstract][Full Text] [Related]
15. Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking. Miller MR; Sigsgaard T; Omland O; Pedersen OF Eur Respir J; 2002 Jul; 20(1):86-91. PubMed ID: 12166587 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. Jónasson G; Carlsen KH; Blomqvist P Eur Respir J; 1998 Nov; 12(5):1099-104. PubMed ID: 9864004 [TBL] [Abstract][Full Text] [Related]
17. PEF variability, bronchial responsiveness and their relation to allergy markers in a random population (20-70 yr). Boezen HM; Postma DS; Schouten JP; Kerstjens HA; Rijcken B Am J Respir Crit Care Med; 1996 Jul; 154(1):30-5. PubMed ID: 8680695 [TBL] [Abstract][Full Text] [Related]
18. Bronchial responsiveness to inhaled histamine in both adults with intrinsic and extrinsic asthma: the importance of prechallenge forced expiratory volume in 1 second. Ulrik CS J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):120-6. PubMed ID: 7678613 [TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow]. Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401 [TBL] [Abstract][Full Text] [Related]
20. Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sample. Higgins BG; Britton JR; Chinn S; Lai KK; Burney PG; Tattersfield AE Thorax; 1993 Sep; 48(9):899-905. PubMed ID: 8236072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]